Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (6): 374-374.
Previous Articles Next Articles
LI Mei
Received:
2018-08-03
Revised:
2018-08-03
Online:
2018-06-15
Published:
2018-08-03
CLC Number:
LI Mei. One Case of Galactorrhea Induced by Itopride Hydrochloride Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(6): 374-374.
[1] 雷俊宝. 伊托比利治疗功能性消化不良的有效性与安全性分析[J]. 世界最新医学信息文摘,2017,17(22):61. [2] 夏菁,孙涛. 罗马罗马Ⅲ诊断标准的制定与功能性胃肠疾病的研究进展[J]. 海军总医院学报,2011, 24(3):166-168. [3] 王跃武. 伊托必利、多潘立酮和甲氧氯普胺联合治疗功能性消化不良的疗效与安全性分析[J]. 现代消化与介入治疗,2017,22(2):215. [4] 丁海英,高春环,许凯. 新型胃肠双动力药物-依托比利[J]. 中国医院药学杂志,2004, 24(2):103-104. [5] 李娜. 徐珞伊托必利、多潘立酮和甲氧氯普胺联合用药对FD患者胃肠功能和Ghrelin表达的影响[J]. 世界华人消化杂志,2010, 18(6): 598. [6] 许大波,柯美云. 新型促胃肠动力药物伊托必利[J]. 中国新药杂志,2002,11(6):437. [7] 赵世丹,鲁仲平. 影响个例药品不良反应报告评价的因素[J]. 中国药物警戒,2012,9(9):553-555. [8] 郭丽,刘浩,潘冬梅,等. 盐酸伊托必利治疗功能性消化不良疗效观察[J]. 临床和试验医学杂志,2014,13(2):139. [9] 吴周龙. 伊托必利治疗功能性消化不良的疗效研究[J]. 中国医药指南,2011, 9(19):291. [10] 董家军,彭逸龙,王海清,等. 雌激素受体及多巴胺受体在泌乳素腺瘤的表达[J]. 中华神经外科疾病研究杂志,2016,15(1):9-11. [11] 张少波. 注射用头孢曲松钠致双侧下肢疼痛1例[J]. 中国药物警戒,2017, 14(1):59. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||